Erbitux Helps Treat Advanced Lung Cancer

Links shared publicly online about this topic.

  • 1,725
    total visits

Erbitux Helps Treat Advanced Lung Cancer

webmd.com

Adding the targeted drug erbitux to standard chemotherapy drugs significantly cuts the risk of death for advanced non-small-cell lung cancer patients -- regardless of what chemotherapy combination is used, a study shows.

View full resource at webmd.com

Tags: Cancer, Chemotherapy, Lung Cancer, Lung, Drug, Erbitux

  • Share

Most Recently Shared on September 24, 2009 at 6:07 pm By:

WebMD_News WebMD_News

Erbitux Helps Treat Advanced Lung Cancer: Adding the targeted drug Erbitux to standard chemotherapy drugs signi.. http://bit.ly/1sOf0N

3 years ago...

Also Shared By:

Heart Health Heart Health

Radiation therapy may not benefit many older lung cancer patients

news-medical.net — “A new study has found that many older lung cancer patients get treatments that may not help them live longer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that physicians should not routinely use radiation after surgery to treat lung cancer that is advanced but has not widely spread, at least in older patients.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on February 13, 2012 at 1:38 pm By:

NewsMedical News-Medical.Net Health News

Radiation therapy may not benefit many older lung cancer patients: A new study has found that many older lung ca... http://t.co/qDlZ3CbR

2 months ago...

FDA Approves Xalkori With Companion Diagnostic For A Type Of Late-stage Lung Cancer - QualityPoint Technologies

qualitypointtech.net — “The U.S. Food and Drug Administration approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene. Xalkori is being approved with a companion diagnostic test that will help determine if a patient has the abnormal ALK gene, a first-of-a-kind genetic test called the Vysis ALK Break Apart FISH Probe Kit. It is the second such targeted therapy approved by tView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on August 27, 2011 at 12:00 pm By:

MedicalFeed MedicalFeed Health News Feed

FDA Approves Xalkori With Companion Diagnostic For A Type Of Late-stage Lung Cancer: The U.S. Food and Drug Admini... http://t.co/6HRx8I6

8 months ago...

FDA Approves Xalkori With Companion Diagnostic For A Type Of Late-stage Lung Cancer - QualityPoint Technologies

qualitypointtech.net — “The U.S. Food and Drug Administration approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene. Xalkori is being approved with a companion diagnostic test that will help determine if a patient has the abnormal ALK gene, a first-of-a-kind genetic test called the Vysis ALK Break Apart FISH Probe Kit. It is the second such targeted therapy approved by tView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on August 27, 2011 at 9:45 am By:

MedicalFeed MedicalFeed Health News Feed

FDA Approves Xalkori With Companion Diagnostic For A Type Of Late-stage Lung Cancer: The U.S. Food and Drug Admini... http://t.co/Dab3lox

8 months ago...

Tumors in majority of patients with advanced lung cancer found to have genetic mutations that can be treated with target

medicalxpress.com — “Screening tumor samples for cancer-causing genetic mutations can help physicians tailor treatment to specifically target those mutations in patients with advanced lung cancer.View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on June 6, 2011 at 3:31 pm By:

FightCancer FightCancer Health News

Tumors in majority of patients with advanced lung cancer found to have genetic mutations that can be treated wit... http://bit.ly/jEMmYi

10 months ago...

New LED device may help advance photodynamic therapy for skin cancer

news-medical.net — “Can skin cancer be treated with light? Scientists at the University of California, Irvine (UC Irvine), believe so. They're exploring new ways to image cancerous lesions using LEDs that might advance a technique for treating cancer called photodynamic therapy (PDT) -- work that they will describe at the Optical Society's (OSA) 94th annual meeting, Frontiers in Optics (FiO) 2010 at the Rochester Riverside Convention Center in Rochester, N.Y., from Oct. 24-28.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 19, 2010 at 5:37 am By:

NewsMedical News-Medical.Net Health News

New LED device may help advance photodynamic therapy for skin cancer: Can skin cancer be treated with light? Scien... http://bit.ly/9pbwWw

2 years ago...

Palliative Care Improves Lung Cancer Patients' Quality Of Life And Helps Them Live Longer - QualityPoint Technologies

qualitypointtech.net — “Patients with advanced lung cancer who received integrated palliative care early on during treatment had a better quality of life and survived for two months longer compared to patients receiving standard care only, according to a study published in the August 19th issue of NEJM (New England Journal of Medicine). Investigators from Massachusetts General Hospital (MGH) explained that metastatic non-small-cell lung cancer (NSCLC) is hard to treat - patients are not generally expected to survive foView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on August 19, 2010 at 12:30 pm By:

MedicalFeed MedicalFeed Health News Feed

Palliative Care Improves Lung Cancer Patients' Quality Of Life And Helps Them Live Longer: Patients with advanced... http://bit.ly/aXhOt5

2 years ago...

Drug extends life for lung cancer patients | News | Nursing Times

nursingtimes.net — “A drug currently used to treat pancreatic cancer could help women with advanced lung cancer as well, new research has indicated.View full resource at nursingtimes.net

  • View Related
  • Share

Most Recently Shared on June 8, 2010 at 9:46 am By:

NursingTimes Nursing Times Health Magazine

News: Drug extends life for lung cancer patients http://bit.ly/altWOE

2 years ago...

A Step Toward Preventing Lung Cancer From Spreading To The Brain And New Clinical Trial Results

feeds.sciencedaily.com — “Medical researchers have announced two significant advances in treating lung cancer. New research could eventually help prevent lung cancer from spreading to the brain. Researchers have also described results from two Phase I clinical trials for a drug called TH-302.View full resource at feeds.sciencedaily.com

  • View Related
  • Share

Most Recently Shared on August 10, 2009 at 8:53 am By:

sciencedaily sciencedaily Health News

A Step Toward Preventing Lung Cancer From Spreading To The Brain And New Clinical Trial Results: Medical researc.. http://bit.ly/AOQsX

3 years ago...

Advertisement